TuHURA Biosciences (HURA) Receivables (2011 - 2015)
TuHURA Biosciences' (HURA) quarterly Receivables came in at $25831.0 in Q2 2015, up 169.86% year-on-year from $9572.0 in Q2 2014, and up 33.56% quarter-over-quarter from $19340.0 in Q3 2014.
TuHURA Biosciences (HURA) Receivables (2011 - 2015) Analysis & Trends
TuHURA Biosciences' Receivables history runs 4 years deep, the most recent figure standing at $25831.0 for Q2 2015.
- On a quarterly basis, Receivables rose 169.86% year-over-year to $25831.0 in Q2 2015; TTM through Jun 2015 was $25831.0, a 169.86% increase from a year earlier, with the FY2015 full-year figure at $25831.0, up 169.86% from the prior year.
- Receivables improved to $25831.0 in Q2 2015 per HURA's latest filing, from $19340.0 in the prior quarter.
- Across five years, Receivables topped out at $45499.0 in Q4 2012 and bottomed at $5000.0 in Q2 2011.
- The 4-year median for Receivables is $19340.0 (2014), against an average of $21048.4.
- Biggest YoY gain for Receivables was 169.86% in 2015; the steepest drop was 169.86% in 2015.
- Year by year, Receivables stood at $5000.0 in 2011, then surged by 809.98% to $45499.0 in 2012, then plunged by 57.49% to $19340.0 in 2014, then soared by 33.56% to $25831.0 in 2015.
- Per Business Quant, the three latest HURA Receivables figures stand at $25831.0 (Q2 2015), $19340.0 (Q3 2014), and $9572.0 (Q2 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 25,831.00 |
| Sep 30, 2014 | 19,340.00 |
| Jun 30, 2014 | 9,572.00 |
| Dec 31, 2012 | 45,499.00 |
| Jun 30, 2011 | 5,000.00 |